Cavitation and Medicines: What to Include in Your Screening History
SaintQueen · Safety and suitability
A useful medication screen starts with a complete history and the exact procedure—not a generic list of “safe” and “unsafe” pills.
Short answer: Before cavitation, disclose every prescription, over-the-counter medicine and supplement, together with doses, recent changes and the conditions being treated. There is no medication clearance list in this article: suitability requires the specific device instructions and a healthcare professional’s assessment. Include every planned attachment, because ultrasound, radiofrequency and light treatments have different warnings. Do not stop, skip or change medicines to qualify for an elective cosmetic session. [1] [2]
What should you put in your medication history?
Bring a current list, or the original packaging if you are unsure of the name or ingredients. Include occasional use as well as daily treatment. The US Department of Health and Human Services recommends recording medicines, vitamins, minerals and herbs, including how much you use and when. [2]
- Prescriptions: tablets, injections, patches, inhalers and prescribed skin treatments.
- Nonprescription products: pain relievers, cold medicines, allergy remedies and medicated creams.
- Supplements: vitamins, minerals, herbal blends, sports supplements and weight-management products. Bring the ingredient label for mixtures.
- Details for each item: name, strength, dose, route, frequency, reason for use and prescriber where relevant.
- Changes and reactions: recent starts, stops or dose changes; known allergies; past adverse reactions; and current symptoms.
Do not leave an item out because it is “natural.” FDA explains that supplements can alter how medicines work and recommends bringing both medication and supplement details to healthcare visits. This supports a complete history; it does not establish a cavitation-specific interaction for every ingredient. [3]
A practical note format
Name and active ingredient → strength and dose → how and when used → reason → recent changes or reactions. Add the proposed device model, attachment and body area on a separate line.
The medical condition matters alongside the medicine. A product name alone does not explain why you take it, how stable your health is or whether the proposed body area has a wound, rash or reduced sensation. Give this context to the clinician reviewing suitability.
Which concerns deserve a specific discussion?
FDA’s body-contouring guidance asks people to disclose blood-thinner treatment, medication-related immune suppression, cancer treatment and current or recent isotretinoin use. These are screening prompts, not one interchangeable ban on every procedure. [1]
| Concern | What to disclose | Question for the professional |
|---|---|---|
| Bleeding or bruising | Anticoagulants, other medicines, supplements and any unusual bleeding or bruising. | Does my history affect the suitability of this exact procedure, including suction or massage? |
| Skin condition or reaction | Medicated skin products, acne treatment, a new rash, damaged skin or a previous treatment reaction. | Does this skin need assessment before any energy treatment? |
| Immune suppression or active treatment | The medication, the condition being treated and current specialist care. | Who should assess the elective procedure in the context of my ongoing care? |
| Light sensitivity | Any medication-label warning about photosensitivity and any previous light reaction. | Is a light-based attachment planned, and what does its own instruction manual say? |
On a narrow screen, swipe within the table to read all three columns.
Blood thinners: disclose them; do not create your own pause
NHS guidance explains that anticoagulants increase susceptibility to bleeding after injury and that other medicines and remedies can affect them. Only a healthcare professional should direct a change. Its discussion of stopping medication for surgery is not a stopping schedule for non-invasive cavitation. [4]
For a combined appointment, ask the operator to identify every planned function. A review of ultrasound alone leaves an unanswered question if suction, massage, radiofrequency or light will also be used. Do not assume that leaving out one attachment resolves all the remaining concerns.
Skin and light warnings need the right context
FDA lists open wounds, lesions and compromised skin as reasons not to undergo its described ultrasound procedures. Its photosensitizing-medication warnings appear in the light-based sections, including low-level light. A light warning should not be presented as proof of an ultrasound–drug interaction. [1]
Report a new skin reaction rather than trying to decide whether the device or a medicine caused it. A clinician can assess the skin and medication history; the exact device instructions remain necessary for the proposed procedure.
Why does the exact treatment matter?
“Cavitation” on an appointment menu is not a complete device description. Ask for the manufacturer, model, applicator, intended use and current instructions for use. Check whether the appointment also includes radiofrequency (RF), light, suction or electrical muscle stimulation.
Keep low-frequency nonfocused cavitation separate from focused mechanical ultrasound, thermal high-intensity focused ultrasound (HIFU), and other ultrasound systems. Do not borrow medication restrictions or reassurance from a different device simply because both use ultrasound.
A study exclusion is not a universal contraindication
A 2025 prospective, uncontrolled study used the 1 MHz MED SmartCool nonfocused ultrasound system. It excluded people taking immunosuppressants or anti-inflammatory medicines, along with other exclusions. Seventeen participants completed treatment, and follow-up extended to two months after the course. [5]
That tells you who was left out of that study. It does not show that every anti-inflammatory medicine is contraindicated with every cavitation machine, or establish safety for excluded patients. The findings also do not clear an unnamed 40K or 80K home device. No research settings from that study are offered here as operating instructions.
Distinguish three kinds of information: a device instruction governs that device’s permitted use; a study exclusion limits the population studied; an individual medical assessment addresses your history. None is a substitute for the others.
What should you do with an unresolved warning?
- Get the procedure details. Request the exact model, every planned attachment, body area and relevant patient information or instructions.
- Take your complete list to a healthcare professional. A pharmacist can clarify ingredients, label warnings and drug interactions. A clinician familiar with your condition should assess medical suitability.
- Ask a focused question. “Do these medicines or the condition they treat affect this procedure, and is anything in the device instructions incompatible with my history?”
- Resolve the concern before proceeding. If the device is unidentified, its instructions are unavailable or a warning remains unanswered, defer the elective session rather than testing a lower setting.
Do not change medication to pass a cosmetic screen
A salon checklist or internet answer is not a prescription-change instruction. Do not skip a dose, switch a medicine or stop prescribed treatment for the appointment. Keep following your medical instructions and contact the prescriber about any proposed change. [2]
Stop a device session if you develop pain, burning, blistering or an unexpected reaction, and seek appropriate medical assessment. FDA describes burns and nerve injury among ultrasound-procedure risks. [1] Tell the clinician which device and attachments were used, where, and when symptoms began.
Common screening mistakes
- Listing only prescriptions and forgetting occasional medicines or supplements.
- Treating “not on the internet contraindication list” as proof of suitability.
- Applying a light-treatment warning to ultrasound without checking the modality.
- Using a study’s excluded medicines as a universal blacklist.
- Accepting a fixed washout period without the prescriber’s assessment.
Frequently asked questions
Do I need to mention a medicine I only use occasionally?
Yes. Include as-needed products and when you last used them. A daily-only list leaves the reviewer with an incomplete history. If you cannot remember an ingredient or dose, bring the package or ask your pharmacist to identify it. [2]
Does taking an antibiotic automatically rule out cavitation?
This article cannot clear or exclude you based on that category alone. Provide the exact medicine, the reason it was prescribed, any current symptoms and the planned device functions. An active illness and a medicine’s warnings are separate questions that need review.
Can I use a home device after a salon says I am unsuitable?
A change of setting or venue does not answer the original concern. Ask what caused the deferral and have it assessed against the home device’s own instructions and your medical history. Do not use home treatment as a workaround for an unresolved warning.
Should I repeat the screen after a medication change?
Update your list and notify the provider before the next session. A previous review was based on the history and procedure available at that time; it should not be treated as permanent clearance after a change.
The useful next step
Prepare a complete medication history and pair it with an identifiable procedure. If a warning cannot be resolved, defer the cosmetic session and keep your prescribed care intact. The goal of screening is an informed suitability decision, not finding a way around a restriction.
Sources and scope
- FDA: Non-Invasive Body Contouring Technologies. Official US guidance; screening and modality-specific warnings. It does not validate an unnamed device.
- HHS MyHealthfinder: Use Medicines Safely. General medication-list and prescription-safety guidance, not cavitation-specific clearance.
- FDA: Mixing Medications and Dietary Supplements Can Endanger Your Health. General interaction and disclosure guidance.
- NHS: Anticoagulant Medicines—Considerations. Medication safety; surgical advice is not transferred to cavitation.
- Tang et al. (2025): Efficacy and safety of non-focused low-intensity ultrasound technology for subcutaneous lipolysis in the lower abdomen. Full text checked; selected participants, 1 MHz system, uncontrolled design and short follow-up.
This article is for general educational purposes and does not provide medical advice. Follow the instructions for the specific device and consult a qualified healthcare professional about suitability and safety.